Related Experiment Video
Updated: Jul 5, 2026

09:06
Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
Published on: December 12, 2025
Development of sorbent therapy for multiple organ dysfunction syndrome (MODS).
1The Key Laboratory of Bioactive Materials, Ministry of Education, Nankai University, Tianjin 300071, People's Republic of China.
Biomedical Materials (Bristol, England)
|May 7, 2008
Summary
Multiple organ dysfunction syndrome (MODS) is a critical condition often caused by sepsis. Adsorption methods effectively remove endotoxins and tumor necrosis factor alpha (TNF-alpha), key contributors to MODS progression.
Area of Science:
- Critical care medicine
- Immunology
- Biomedical engineering
Background:
- Multiple Organ Dysfunction Syndrome (MODS) is a leading cause of mortality in intensive care units.
- Endotoxins from Gram-negative bacteria and cytokines like tumor necrosis factor alpha (TNF-alpha) are pivotal in MODS pathogenesis.
- Systemic inflammatory response syndrome (SIRS) and septic shock are common precursors to MODS.
Purpose of the Study:
- To review various adsorption methods for removing endotoxins and TNF-alpha.
- To highlight the efficacy of adsorption in managing MODS.
- To provide insights into novel adsorbent materials and techniques.
Main Methods:
- Literature review of studies on endotoxin and TNF-alpha adsorption.
- Analysis of different adsorbent materials (e.g., polymyxin B, activated carbon).
- Evaluation of adsorption techniques in preclinical and clinical settings.
Main Results:
- Adsorption demonstrates significant potential in clearing endotoxins and TNF-alpha from circulation.
- Various adsorbents show varying degrees of efficiency and specificity.
- The removal of these inflammatory mediators can mitigate organ damage in MODS models.
Conclusions:
- Adsorption therapy is a promising strategy for treating MODS.
- Further research into optimized adsorbents and treatment protocols is warranted.
- Targeting endotoxins and TNF-alpha via adsorption offers a viable therapeutic avenue for critical care.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
